ClinicalTrials.gov
ClinicalTrials.gov Menu

Level of Physical Activities in Patients Before and After Breast Cancer Treatment (PABC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00517088
Recruitment Status : Completed
First Posted : August 16, 2007
Last Update Posted : May 30, 2014
Sponsor:
Information provided by:
UPECLIN HC FM Botucatu Unesp

Brief Summary:
Subjects and Methods: 303 patients who had already had the diagnosis of breast cancer and had already been treated at the Ambulatory of Botucatu School of Medicine were selected. The measuring tool used for the level of physical activities was the International Physical Activities Questionnaire (IPAQ-short version), validated by the World Health Organization - Physical Activities and Health International Committee (1998).

Condition or disease Intervention/treatment Phase
Breast Cancer Drug: IPAQ Not Applicable

UPECLIN HC FM Botucatu Unesp has indicated that access to an investigational treatment associated with this study is available outside the clinical trial.  

Detailed Description:
Introduction: Breast cancer is the most common malignant neoplasy in women. The risk for breast cancer in a lifetime is high among north-american women, about one out of eight, with 66% of the cases occurring after menopause and 15% when women are under 40 years old. Published cohort studies show clear evidences that women who practice intense physical activities have the risk for breast cancer reduced. The risk reduction for these women is 70%, and 10% for those who practice physical activities at a low level. During adolescence and adult age, moderate to intense physical activities may protect against a future breast cancer development. But some questions still need to be answered: Were women with a breast carcinoma diagnosis already physically active during life? Were there changes in these physical activities after treatment? Why? Objectives: The aim of this study was to identify the level of physical activities in patients before and after breast carcinoma treatment, and to observe if there were changes in the level of these activities. Subjects and Methods: 303 patients who had already had the diagnosis of breast cancer and had already been treated at the Ambulatory of Botucatu School of Medicine were selected. The measuring tool used for the level of physical activities was the International Physical Activities Questionnaire (IPAQ-short version), validated by the World Health Organization - Physical Activities and Health International Committee (1998).

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 2007 participants
Intervention Model: Single Group Assignment
Masking: Single (Participant)
Official Title: Level of Physical Activities in Patients Before and After Breast Cancer Treatment
Study Start Date : May 2006
Actual Study Completion Date : March 2007

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Other
Group Description
Drug: IPAQ



Primary Outcome Measures :
  1. breast cancer [ Time Frame: one year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Patients whit diagnosis of breast cancer

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00517088


Sponsors and Collaborators
UPECLIN HC FM Botucatu Unesp
Investigators
Principal Investigator: Flávio G Pinto UPECLIN HC FM Botucatu Unesp

ClinicalTrials.gov Identifier: NCT00517088     History of Changes
Other Study ID Numbers: upeclin/HC/FMB-Unesp-pre03
First Posted: August 16, 2007    Key Record Dates
Last Update Posted: May 30, 2014
Last Verified: August 2007

Keywords provided by UPECLIN HC FM Botucatu Unesp:
Physical Activity
Breast Cancer

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases